Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Why are Cancer Cell Lines Useful?

What is Cancer of Unknown Primary?

Cancer Classification

Cancer Glossary

Cancer Diagnosis

Cancer History

Cancer Pathophysiology

Assay for Monitoring and Treating Malignant Brain Tumors

British Pioneers in Cancer Biology

Cancer Symptoms

See more featured articles »

Pediatric Cancer

Transforming Cancer Care through Genomic Testing

Living with Cancer Pain

Is Cancer a Metabolic Disorder?

Using Biomarkers to Detect Cancer

What is Cancer?

Overview of Cell Viability and Cytotoxicity

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer Screening Considerations: Balancing the Benefits and Risks

Secondary Brain Cancer

Cancer Pain

What is the Tumor Microenvironment?

Cancer Prevention: Lowering your Risk

Cancer Epidemiology

Cancer Management

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

The Cancer Cell Surface Proteome as a Therapeutic Target

Caring for a Loved One with Cancer

What Role do Biobanks Play in Cancer Research?

Metastatic Migration in Cancer may be Influenced by Metabolism

What is Immunochemotherapy?

Targeted Cancer Therapies

What is Tumorigenesis?

Cutaneous Manifestations of Internal Malignancy

Effects of Social and Economic Deprivation on Cancer Mortality

Exploiting Enzymes in Cancer Diagnosis and Therapy

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Extracellular Vesicles as Floating Cancer Biomarkers

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Pain Management

Acidosis and Tumor Progression

Myc Mutations and Cancer

What Causes Cancer?

Insights into Oncofertility

Investigating the Molecular Mechanisms of Cancer

Microfluidic cancer treatment screen combined with flow cytometry

Hypoxia Markers and Their Importance

What is Merkel Cell Carcinoma?

Cancer Research

The Effects of Cancer on Family Life

Secondary Lung Cancer

Insight into Cancer Vaccines

Hot vs Cold: the differences between tumor types

The Biochemistry of Breast Cancer Screening

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer Prognosis

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

CDK9 and Cancer

Latest Cancer News and Research

Coffee impacts the gut-brain axis to improve mood and stress

New research from APC Microbiome Ireland, a world leading research centre at University College Cork, has comprehensively explored the mechanisms behind coffee's positive effects on the gut-brain axis for the first time.

21 Apr 2026

Rising colorectal cancer rates in young Swiss adults spark concern

While the incidence of colorectal cancer is decreasing among those over 50, it is rising at an alarming rate among younger individuals, sometimes as early as their thirties.

21 Apr 2026

AI chatbots give misleading health advice nearly half the time

Widespread inaccuracies in AI chatbot health responses pose public health risks, highlighting the urgent need for better oversight and cleaner training data.

21 Apr 2026

Long-term exposure to air pollution (PM2.5) raises risk of developing cancer by 11 % and of dying from cancer by 12 %

The Union for International Cancer Control (UICC), with support from the Clean Air Fund, has released a global report, Clean air in cancer control: An overview of the evidence, presenting data on the scale of cancer risk and mortality from polluted air.

21 Apr 2026

DNA methylation "fingerprints" identify primary sites in metastatic cancers

A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.

21 Apr 2026

Ibuprofen shown to improve cognitive function in patients undergoing chemotherapy

Researchers have already shown that mild to moderate exercise can reduce "chemo brain," and a new study suggests that a low dose of an over-the-counter anti-inflammatory, ibuprofen, can also achieve positive results for cancer patients.

21 Apr 2026

Phase I NSCLC trials shrink and cluster in major U.S. cities

Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decreased by 44% and became increasingly concentrated at the top 20 highest‑volume clinical trial sites largely located in major cities, according to results presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.

21 Apr 2026

Multimodal AI improves prediction of PIK3CA mutations in breast cancer

Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway are prevalent in its development.

21 Apr 2026

Muscle energy recovery may explain fatigue in cancer survivors

Even apparently healthy cancer survivors often complain of extreme fatigue. They have finished treatment, the scans are clear, but they feel hollowed out, unable to walk to the mailbox or stay awake through dinner.

21 Apr 2026

APC-deficient cancer cells rely on single enzyme for survival

A newly published study reports that APC-deficient cancer cells may depend on a single metabolic enzyme for survival, revealing a potential strategy for selectively targeting tumours associated with one of the most common mutations in colorectal cancer.

20 Apr 2026

Trial shows safety of novel KIR-CAR T therapy in solid tumors

An innovative type of CAR T cell therapy, called KIR-CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine patients with advanced ovarian cancer, mesothelioma or cholangiocarcinoma (bile duct cancer), according to an early report from an ongoing Phase I dose-escalation clinical trial.

20 Apr 2026

Microbial "signatures" within the oral cavity and gut may aid in gastric cancer detection

A recent study published in Cell Reports Medicine has identified distinct microbial "signatures" within the oral cavity and gut that serve as robust biomarkers for the early detection of gastric cancer (GC).

20 Apr 2026

Study creates genetic roadmap of how HIV virus interacts with human cells

The human immunodeficiency virus (HIV), which is the cause of AIDS, is a master of deception, using just nine genes to hijack the complex cellular machinery of the human body.

20 Apr 2026

Trial shows durable response with preoperative immunotherapy in bowel cancer

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of follow-up, according to new results from the NEOPRISM-CRC clinical trial led by a team from UCL and UCLH.

20 Apr 2026

Single CAR T infusion shows strong response in smoldering multiple myeloma patients

A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in patients with high-risk smoldering multiple myeloma, according to results from CAR-PRISM, a phase II clinical trial, presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.

20 Apr 2026

AI improves imaging pathology and treatment decisions in breast cancer

Breast cancer is the most common cancer among women, with over 2.3 million new cases diagnosed each year. Traditional diagnostic methods rely heavily on human judgment, which can lead to inconsistent outcomes.

20 Apr 2026

AI model predicts immunotherapy response in lung cancer patients

A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC), according to a study presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.

20 Apr 2026

Targeting glutamine metabolism enhances CAR-macrophage cancer therapy

Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) exhibit significant metabolic dysregulation, which impairs their antitumor function.

20 Apr 2026

Scientists disrupt key cancer proteins to target neuroblastoma

Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with each other.

20 Apr 2026

Certain prenatal medications linked to increased risk of autism

A landmark study led by researchers at the University of Nebraska Medical Center (UNMC) and published in Molecular Psychiatry has identified a significant association between prenatal prescription of commonly utilized medications and the risk of autism spectrum disorder (ASD) in children.

20 Apr 2026